Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study

Journal:

Clinical Infectious Diseases

Published:

2026-03-14

DOI:

10.1093/cid/ciag171

Affiliations:

34

Authors:

37

Go to article

Institutions	Authors	Share
Merck - Rahway, United States of America (USA)	8.000000	0.22
University of the Witwatersrand, Johannesburg (Wits University), South Africa	2.000000	0.05
Chulalongkorn University (CU), Thailand	1.500000	0.04
University of California, Los Angeles (UCLA), United States of America (USA)	1.000000	0.03
Vía Libre Foundation, Peru	1.000000	0.03
Orlando Immunology Center (OIC), United States of America (USA)	1.000000	0.03
Gordon E. Crofoot MD, PA, United States of America (USA)	1.000000	0.03
Central Texas Clinical Research, United States of America (USA)	1.000000	0.03
San Francisco Department of Public Health (SFDPH), United States of America (USA)	1.000000	0.03
The University of Alabama at Birmingham (UAB), United States of America (USA)	1.000000	0.03
University of Mississippi Medical Center (UMMC), Ole Miss, United States of America (USA)	1.000000	0.03
Midway Immunology Research Center, United States of America (USA)	1.000000	0.03
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)	1.000000	0.03
Emory University, United States of America (USA)	1.000000	0.03
Centro de Referência e Treinamento DST/Aids-SP, Brazil	1.000000	0.03
Chiang Mai University (CMU), Thailand	1.000000	0.03
Howard Brown Health, United States of America (USA)	1.000000	0.03
Rutgers, The State University of New Jersey (RU), United States of America (USA)	1.000000	0.03
University of Miami (UM), United States of America (USA)	1.000000	0.03
Global Research Institute, United States of America (USA)	1.000000	0.03
The George Washington University (GW), United States of America (USA)	1.000000	0.03
National Institute of Global Health and Medicine, Japan	1.000000	0.03
Oswaldo Cruz Foundation (FIOCRUZ), Brazil	1.000000	0.03
The Aurum Institute, South Africa	1.000000	0.03
Asociación Civil Impacta Salud y Educación, Peru	1.000000	0.03
Josha Research, South Africa	1.000000	0.03
Hôpital Lariboisière, France	0.833333	0.02
Institut de Recherche Saint-Louis (IRSL), France	0.500000	0.01
HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Thailand	0.500000	0.01
Infection, Antimicrobials, Modelling, Evolution (IAME), France	0.333333	0.01
Hôpital Saint-Louis, France	0.333333	0.01

Interested in Clinical Sciences?